ACA
MRK icon

Ackerman Capital Advisors’s Merck MRK Stock Holding History

Ackerman Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,229
Closed -$335K – 138
2020
Q3 		$335K Buy
4,229
+37
+0.9% +$2.9K 0.09% 76
2020
Q2 		$309K Buy
+4,192
New +$316K 0.09% 77

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Ackerman Capital Advisors's MRK Position: Q4 2020 in Review

Ackerman Capital Advisors sold out of Merck (MRK) in Q4 2020, closing a stake of 4,229 shares — an estimated $335K sold.

Ackerman Capital Advisors first reported a position in MRK in Q2 2020 and held it in 2 quarters. The position peaked at $335K in Q3 2020. 2,709 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Ackerman Capital Advisors reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Ackerman Capital Advisors sold 4,229 Merck shares in Q4 2020, an estimated $335K.
  • Ackerman Capital Advisors first reported a position in Merck in Q2 2020 and held it in 2 quarters.
  • Ackerman Capital Advisors's Merck position peaked at $335K in Q3 2020.
  • 2,709 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Ackerman Capital Advisors's 13F filing for Q4 2020, filed 1 Feb 2021.